Epcoritamab Bispecific - 搜索图片

540×540
bloodcancerwa.org.au
Epcoritamab, a Novel, Subcutaneous CD3x…
604×270
creative-biolabs.com
Epcoritamab – Creative Biolabs Bispecific Antibody Blog
2372×966
biocentury.com
BioCentury - Epcoritamab shows best-in-class potential for DLBCL
724×483
trialsitenews.com
AbbVie, Genmab’s Bispecific Antibody Epcoritamab Achieves Hi…

6475×6391
cancernetwork.com
Epcoritamab Approval Expands Bispecific Use …
474×256
creative-biolabs.com
Bispecific Antibody Research Update: Epcoritamab Receives FDA Priority Review – Creative Biolabs ...
1200×628
linkedin.com
CLL Society on LinkedIn: Epcoritamab is a bispecific antibody being tested in clinical trials as a…
300×300
antibodysociety.org
FDA approves bispecific antibody EPKINLY™ (e…

1920×1080
zhuanlan.zhihu.com
Epcoritamab有效率88%，双抗治疗肿瘤时代或将到来 - 知乎
640×433
zhuanlan.zhihu.com
从Linvoseltamab最新临床数据公布，看BCMA/CD3双抗研究进展 - 知乎
3:32
youtube.com > Mr. Lightyear
Epcoritamab (Epkinly), a novel bispecific antibody to target cancer cells
YouTube · Mr. Lightyear · 559 次播放 · 2023年6月16日

6:06
youtube.com > GRACE - Global Resource for Advancing Cancer Education
Bispecific Antibody Treatment in Non-Hodgkin Lymphoma: Epcoritamab - Blood Cancers OncTalk 2023
YouTube · GRACE - Global Resource for Advancing Cancer Education · 143 次播放 · 11 个月之前
1200×600
twitter.com
Raul Cordoba, MD, PhD on Twitter: "RT @lymphomahub: 🚨 NEWS 🚨 The @US_FD…
560×373
firstwordpharma.com
AbbVie, Genmab's bispecific Tepkinly backed for approval i…
1200×630
fa.news
FDA approves Epkinly epcoritamab-bysp as first and only T-cell engaging bispecif…

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果